Literature DB >> 3709649

Excretion of noscapine in human breast milk.

B Olsson, P Bolme, B Dahlström, C Marcus.   

Abstract

The excretion of noscapine in human breast milk was studied in 8 lactating women given a single oral dose of 100 or 150 mg after a light breakfast. Serum and milk samples were collected for 24 h after drug intake. Although noscapine is a weak base, only a small amount was excreted in the milk. The median milk/serum ratio was 0.29, range 0.15-0.88. The noscapine dose received by a child during a 24 hour period, when the maternal dose is 50 mg t.i.d., was calculated to be 0.8 (0.4-1.9) micrograms/kg (median and range).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709649     DOI: 10.1007/bf00614306

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Absorption and excretion of noscapine.

Authors:  S VEDSO
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

2.  Determination of noscapine in plasma by liquid chromatography.

Authors:  M Johansson; S Eksborg; A Arbin
Journal:  J Chromatogr       Date:  1983-07-08

3.  [Objectivation of the effect of antitussive agents using tussometry in patients with chronic cough].

Authors:  H Matthys; J Erhardt; K H Rühle
Journal:  Schweiz Med Wochenschr       Date:  1985-03-02

4.  Pharmacokinetic properties of noscapine.

Authors:  B Dahlström; T Mellstrand; C G Löfdahl; M Johansson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  4 in total
  6 in total

1.  Noscapine recirculates enterohepatically and induces self-clearance.

Authors:  Rao Mukkavilli; Sushma R Gundala; Chunhua Yang; Gajanan R Jadhav; Subrahmanyam Vangala; Michelle D Reid; Ritu Aneja
Journal:  Eur J Pharm Sci       Date:  2015-05-28       Impact factor: 4.384

2.  Molecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cells.

Authors:  Jitender Madan; Bharat Baruah; Mulpuri Nagaraju; Mohamed O Abdalla; Clayton Yates; Timothy Turner; Vijay Rangari; Donald Hamelberg; Ritu Aneja
Journal:  Mol Pharm       Date:  2012-04-27       Impact factor: 4.939

3.  Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

Authors:  Nan Zhang; Ryan P Seguin; Kent L Kunze; Yan-Yan Zhang; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2013-09-17       Impact factor: 3.922

Review 4.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

6.  Cyclodextrin complexes of reduced bromonoscapine in guar gum microspheres enhance colonic drug delivery.

Authors:  Jitender Madan; Sushma R Gundala; Bharat Baruah; Mulpuri Nagaraju; Clayton Yates; Timothy Turner; Vijay Rangari; Donald Hamelberg; Michelle D Reid; Ritu Aneja
Journal:  Mol Pharm       Date:  2014-11-18       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.